Scholarly Index
Zhongyan Shan
First Hospital of China Medical University; 21,142 total citations; 448 total publications; best world rank #2
First Hospital of China Medical University
21,142Total citations
448Total publications
67H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Thyroid Disorders and Treatments | Lifetime | 45 | CN 1 | 99.27 |
| Thyroid Cancer Diagnosis and Treatment | Lifetime | 142 | CN 1 | 98.95 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 651 | CN 7 | 97.19 |
| Vitamin D Research Studies | Lifetime | 575 | CN 7 | 96.27 |
| Biomarkers in Disease Mechanisms | Lifetime | 904 | CN 82 | 79.94 |
| Thyroid Disorders and Treatments | 2021-2025 | 2 | CN 1 | 99.45 |
| Thyroid Cancer Diagnosis and Treatment | 2021-2025 | 23 | CN 3 | 98.78 |
| Vitamin D Research Studies | 2021-2025 | 52 | CN 1 | 95.91 |
| Growth Hormone and Insulin-like Growth Factors | 2021-2025 | 50 | CN 1 | 96.67 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 798 | CN 182 | 85.85 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 728 | CN 89 | 82.66 |
| Diet, Metabolism, and Disease | 2021-2025 | 774 | CN 150 | 83.60 |
| Adrenal Hormones and Disorders | 2021-2025 | 666 | CN 35 | 70.76 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 415 | CN 143 | 59.81 |
| Hypothalamic control of reproductive hormones | 2021-2025 | 618 | CN 68 | 53.17 |